Literature DB >> 10425676

Pyruvate formate lyase is structurally homologous to type I ribonucleotide reductase.

V M Leppänen1, M C Merckel, D L Ollis, K K Wong, J W Kozarich, A Goldman.   

Abstract

BACKGROUND: Pyruvate formate lyase (PFL) catalyses a key step in Escherichia coli anaerobic glycolysis by converting pyruvate and CoA to formate and acetylCoA. The PFL mechanism involves an unusual radical cleavage of pyruvate, involving an essential C alpha radical of Gly734 and two cysteine residues, Cys418 and Cys419, which may form thiyl radicals required for catalysis. We undertook this study to understand the structural basis for catalysis.
RESULTS: The first structure of a fragment of PFL (residues 1-624) at 2.8 A resolution shows an unusual barrel-like structure, with a catalytic beta finger carrying Cys418 and Cys419 inserted into the centre of the barrel. Several residues near the active-site cysteines can be ascribed roles in the catalytic mechanism: Arg176 and Arg435 are positioned near Cys419 and may bind pyruvate/formate and Trp333 partially buries Cys418. Both cysteine residues are accessible to each other owing to their cis relationship at the tip of the beta finger. Finally, two clefts that may serve as binding sites for CoA and pyruvate have been identified.
CONCLUSIONS: PFL has striking structural homology to the aerobic ribonucleotide reductase (RNR): the superposition of PFL and RNR includes eight of the ten strands in the unusual RNR alpha/beta barrel as well as the beta finger, which carries key catalytic residues in both enzymes. This provides the first structural proof that RNRs and PFLs are related by divergent evolution from a common ancestor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425676     DOI: 10.1016/S0969-2126(99)80098-7

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  8 in total

1.  Structural basis for glycyl radical formation by pyruvate formate-lyase activating enzyme.

Authors:  Jessica L Vey; Jian Yang; Meng Li; William E Broderick; Joan B Broderick; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

2.  Quantitative comparison of catalytic mechanisms and overall reactions in convergently evolved enzymes: implications for classification of enzyme function.

Authors:  Daniel E Almonacid; Emmanuel R Yera; John B O Mitchell; Patricia C Babbitt
Journal:  PLoS Comput Biol       Date:  2010-03-12       Impact factor: 4.475

3.  A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline.

Authors:  B J Levin; Y Y Huang; S C Peck; Y Wei; A Martínez-Del Campo; J A Marks; E A Franzosa; C Huttenhower; E P Balskus
Journal:  Science       Date:  2017-02-10       Impact factor: 47.728

4.  AdoMet radical proteins--from structure to evolution--alignment of divergent protein sequences reveals strong secondary structure element conservation.

Authors:  Yvain Nicolet; Catherine L Drennan
Journal:  Nucleic Acids Res       Date:  2004-08-02       Impact factor: 16.971

5.  1,2-Propanediol Dehydration in Roseburia inulinivorans: STRUCTURAL BASIS FOR SUBSTRATE AND ENANTIOMER SELECTIVITY.

Authors:  Joseph W LaMattina; Nicholas D Keul; Pierre Reitzer; Suraj Kapoor; Felipe Galzerani; Daniel J Koch; Iuri E Gouvea; William N Lanzilotta
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

6.  The case for an early biological origin of DNA.

Authors:  Anthony M Poole; Nobuyuki Horinouchi; Ryan J Catchpole; Dayong Si; Makoto Hibi; Koichi Tanaka; Jun Ogawa
Journal:  J Mol Evol       Date:  2014-11-26       Impact factor: 2.395

Review 7.  Structural diversity in the AdoMet radical enzyme superfamily.

Authors:  Daniel P Dowling; Jessica L Vey; Anna K Croft; Catherine L Drennan
Journal:  Biochim Biophys Acta       Date:  2012-04-28

Review 8.  New tricks for the glycyl radical enzyme family.

Authors:  Lindsey R F Backman; Michael A Funk; Christopher D Dawson; Catherine L Drennan
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-09-13       Impact factor: 8.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.